CWG
C WorldWide Group Portfolio holdings
AUM
$7.38B
This Quarter Return
+6.1%
1 Year Return
+18.35%
3 Year Return
+71.53%
5 Year Return
+105.42%
10 Year Return
+360.65%
AUM
$8.04B
AUM Growth
+$8.04B
(+2.1%)
Cap. Flow
-$241M
Cap. Flow
% of AUM
-3%
Top 10 Holdings %
Top 10 Hldgs %
72.74%
Holding
123
New
10
Increased
29
Reduced
37
Closed
41
Top Buys
| 1 |
MSCI
MSCI
|
$183M |
| 2 |
Elevance Health
ELV
|
$31.9M |
| 3 |
Alphabet (Google) Class C
GOOG
|
$15.2M |
| 4 |
Intuitive Surgical
ISRG
|
$15.1M |
| 5 |
Teleflex
TFX
|
$14.9M |
Top Sells
| 1 |
Visa
V
|
$148M |
| 2 |
Johnson & Johnson
JNJ
|
$46.1M |
| 3 |
Ecolab
ECL
|
$44.2M |
| 4 |
UnitedHealth
UNH
|
$33.9M |
| 5 |
Pfizer
PFE
|
$33.4M |
Sector Composition
| 1 | Financials | 24.06% |
| 2 | Consumer Discretionary | 16.59% |
| 3 | Healthcare | 13.94% |
| 4 | Consumer Staples | 10.32% |
| 5 | Materials | 7.75% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
|
76
Pfizer
PFE
$141B
| $565K | 0.01% | 13,033 -771,120 | -98% | -$33.4M |
|
77
Mercado Libre
MELI
$125B
| $482K | 0.01% | +787 | New | +$482K |
|
78
Fidelity National Information Services
FIS
$36.5B
| $441K | 0.01% | 3,597 -2,714 | -43% | -$333K |
|
|
79
Johnson & Johnson
JNJ
$427B
| $428K | 0.01% | 3,073 -331,047 | -99% | -$46.1M |
|
80
GeoPark
GPRK
$340M
| $265K | ﹤0.01% | 14,307 -3,598 | -20% | -$66.6K |
|
81
Autohome
ATHM
$3.42B
| $208K | ﹤0.01% | +2,423 | New | +$208K |
|
82
PagSeguro Digital
PAGS
$2.62B
| $192K | ﹤0.01% | +4,941 | New | +$192K |
|
83
Amgen
AMGN
$155B
| – | – | -80,787 | Closed | -$15.3M |
|
84
AbbVie
ABBV
$372B
| – | – | -125,780 | Closed | -$10.1M |
|
85
Acadia Healthcare
ACHC
$2.12B
| – | – | -53,712 | Closed | -$1.57M |
|
86
Aclaris Therapeutics
ACRS
$209M
| – | – | -148,506 | Closed | -$890K |
|
87
Aramark
ARMK
$10.3B
| – | – | -65,015 | Closed | -$1.92M |
|
88
Avery Dennison
AVY
$13.4B
| – | – | -3,500 | Closed | -$396K |
|
89
Becton Dickinson
BDX
$55.3B
| – | – | -52,955 | Closed | -$13.2M |
|
90
Biogen
BIIB
$19.4B
| – | – | -41,551 | Closed | -$9.82M |
|
91
Boston Scientific
BSX
$156B
| – | – | -367,194 | Closed | -$14.1M |
|
92
Cigna
CI
$80.3B
| – | – | -30,018 | Closed | -$4.83M |
|
93
Collegium Pharmaceutical
COLL
$1.22B
| – | – | -236,021 | Closed | -$3.57M |
|
94
Gilead Sciences
GILD
$140B
| – | – | -196,598 | Closed | -$12.8M |
|
95
HCA Healthcare
HCA
$94.5B
| – | – | -112,905 | Closed | -$14.7M |
|
96
Hologic
HOLX
$14.9B
| – | – | -199,328 | Closed | -$9.65M |
|
97
Incyte
INCY
$16.5B
| – | – | -38,726 | Closed | -$3.33M |
|
98
Iovance Biotherapeutics
IOVA
$807M
| – | – | -226,681 | Closed | -$2.16M |
|
99
Jazz Pharmaceuticals
JAZZ
$7.75B
| – | – | -29,774 | Closed | -$4.26M |
|
100
LivaNova
LIVN
$3.08B
| – | – | -83,163 | Closed | -$8.09M |
|